mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |